In conclusion, our data suggest a critical function of Prf1-mediated T-cell neurotoxicity during retinal injury, indicating that targeting infiltrating Prf1+ and CD8+ T cells may be a potential treatment for retinal degeneration. The gene discussed is CD8A; the disease is retinal degeneration.